Current NDC auxiliary source row compounder:539

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 69852-204
Product Ndc: 69852-204
Product Ndc Digits: 69852204
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Benzocaine/Lidocaine/Tetracaine
Proprietary Name Suffix: [empty]
Nonproprietary Name: Benzocaine/Lidocaine/Tetracaine
Dosage Form Name: OINTMENT
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Eagle Pharma Outsourcing, LLC
Establishment Name: Eagle Pharma Outsourcing, LLC
Establishment Fei: [empty]
Substance Name: LIDOCAINE; TETRACAINE; BENZOCAINE
Active Ingredients Info: 3.6 g/45 g; 1.8 g/45 g; 9 g/45 g
History Active Ingredients Raw: LIDOCAINE; TETRACAINE; BENZOCAINE
History Active Ingredients Info Raw: 3.6 g/45 g; 1.8 g/45 g; 9 g/45 g
History Dosage Raw: OINTMENT
Dea Schedule: [empty]
Package Ndc Raw: 69852-204-45
Package Ndc: 69852-204-45
Package Ndc Digits: 6985220445
Package Ndc11: 69852020445
Package Description: 14.4 g in 1 BOTTLE, PUMP (69852-204-45)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:539
Source Row Number: 539
Source Row Hash: d96cc7fad72ffb957441da6f3db133c2bca41677759a185739f1f8253d174b56
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "69852-204",
    "DEASCHEDULE": "",
    "LABELERNAME": "Eagle Pharma Outsourcing, LLC",
    "SUBSTANCENAME": "LIDOCAINE; TETRACAINE; BENZOCAINE",
    "DOSAGEFORMNAME": "OINTMENT",
    "NDCPACKAGECODE": "69852-204-45",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Benzocaine/Lidocaine/Tetracaine",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Benzocaine/Lidocaine/Tetracaine",
    "PACKAGEDESCRIPTION": "14.4 g in 1 BOTTLE, PUMP (69852-204-45) ",
    "ACTIVEINGREDIENTSINFO": "3.6 g/45 g; 1.8 g/45 g; 9 g/45 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:539
Source Row Number: 539
Status Scope: package
Lookup Ndc: 69852-204-45
Lookup Ndc Digits: 6985220445
Product Ndc: 69852-204
Product Ndc Digits: 69852204
Package Ndc: 69852-204-45
Package Ndc Digits: 6985220445
Package Ndc11: 69852020445
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: d96cc7fad72ffb957441da6f3db133c2bca41677759a185739f1f8253d174b56
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20